Global Atrial Fibrillation Devices Market Size, Share, Analysis, Industry Report and Forecast 2019-2025
The global Atrial Fibrillation
Devices Market is estimated to grow significantly at a CAGR
of 13.7% during the forecast period. The growing prevalence of atrial
fibrillation diseases is estimated to be one of the major factors that are
driving the growth of the atrial fibrillation market across the globe. Atrial
filtration is the most common arrhythmia with a prevalence of 1% to 2% in the
population. The prevalence of atrial fibrillation is continuously rising owing
to the increase in the geriatric population.
To Request a Sample of our Report on Global Atrial Fibrillation Devices Market: https://www.omrglobal.com/request-sample/atrial-fibrillation-devices-market
Atrial fibrillation is the
major cause of stroke and accounts for 25% of acute ischemic strokes in
patients with the age of more than 80 years of age as compared with 10% to 15%
in all age groups. The stroke preventive strategies in patients along with
atrial fibrillation and outcome have improved as a result of a reduction in the
mortality and cost of acute ischemic stroke in atrial fibrillation patients.
Electrophysiology enables in to identify the mechanism of a large QRS
tachycardia, sites for AV node ablation and predisposing arrhythmia.
According to the Institute for Health Metrics and Evaluation, the prevalence of atrial fibrillation in 2013 was 33.6 million peoples, which increased to 37.5 million in 2017. Keeping the close look in the sedentary lifestyle of the people across the globe, this number is further expected to increase in the near future. This would augment the market growth of the global Global Atrial Fibrillation Devices Market.
There is a significant rise
witnessed in the adoption of minimally invasive surgeries, which is supporting
the use of innovative atrial fibrillation devices by considering efficacy and
safety associated with the device. For instance, the non-invasive imaging of
cardiac electrophysiology performed by the fusing data forms high- resolution
electrocardiogram mapping with a model of patient’s individual cardiothoracic
anatomy created from magnetic resonance imaging (MRI).
The less invasive imaging provides minimally invasive ventricular activation that can be essential for CRT patients to locate the area of the latest ventricular activation. With the advancement of minimally invasive pacemakers, implantable cardiac defibrillator and ablation catheters further raise the demand for minimally invasive electrophysiology methods that further propel the market growth.
A full Report of Global Atrial Fibrillation Devices Market
is Available at: https://www.omrglobal.com/industry-reports/atrial-fibrillation-devices-market
·
On the basis of the product type, the
electrophysiology mapping and recording systems segment are estimated to hold a
significant market share during the forecast period.
·
Asia-Pacific is estimated to gain maximum
traction in the global atrial fibrillation devices industry during the forecast
period.
·
Based on the end-use segment, the ambulatory
surgery centers segment is estimated to foresee an optimistic growth rate over
the forecast period.
Global Global Atrial Fibrillation Devices Market
Segmentation
By Product Type
·
Electrophysiology Ablation Catheters
·
Electrophysiology Diagnostic Catheters
·
Electrophysiology Mapping and Recording Systems
·
Cardiac Monitors
·
Others
By End-Use
·
Hospitals
·
Ambulatory Surgery Centers (ASCs)
Regional
Analysis
North America
·
United
States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of
Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest of
APAC
Rest of The
World
·
Latin
America
·
Middle
East and Africa
Company
Profiles
·
Abbott
Laboratories Inc.
·
AblaCor
Medical Corp.
·
AtriCure,
Inc.
·
Biomerics,
LLC
·
Biotronik,
Inc.
·
Boston
Scientific Corp.
·
CardioFocus,
Inc.
·
CathVision
ApS
·
General
Electric Co.
·
Integer
Holdings Corp.
·
Japan
Lifeline Co., Ltd.
·
Johnson
& Johnson (Biosense Webster, Inc.)
·
Koninklijke
Philips N.V.
·
Medtronic
PLC
·
Microport
Scientific Corp.
·
Millar,
Inc.
·
Molecular
Devices, LLC
·
Rhythmlink
International, LLC
·
Sanofi
SA
·
Stryker
Corp.
·
Transonic
Systems, Inc.
Reasons to Buying From us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/atrial-fibrillation-devices-market
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment